Related Experiment Videos
Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation
S G Qiu1, S Krishnan, N el-Guendy
1Department of Surgery, University of Kentucky, Lexington 40536, USA.
Abstract:
Oncogenic variants of the cellular Ras protein are often associated with different types of human cancers. However, the mechanisms by which oncogenic Ras induces transformation are not fully established. Expression of the transcriptional repressor Par-4 was down-regulated by oncogenic Ras via the Raf-MEK-ERK pathway. Restoration of Par-4 levels by abrogation of the Raf-MEK-ERK pathway with the MEK-inhibitor PD98059 or by ectopic Par-4, that acted to inhibit ERK expression and activation, was sufficient to suppress oncogenic Ras-induced transformation. These findings identify Par-4 as a novel target that has to be down-modulated by oncogenic Ras for successful transformation.
Insights
Oncogenic Ras proteins, linked to cancer, down-regulate the Par-4 repressor via the Raf-MEK-ERK pathway. Restoring Par-4 inhibits Ras-induced transformation, identifying it as a key target in cancer development.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Signaling
Background:
- Oncogenic Ras proteins are frequently implicated in human cancers.
- The precise mechanisms driving Ras-induced cellular transformation remain incompletely understood.
- Understanding these pathways is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of the transcriptional repressor Par-4 in oncogenic Ras-mediated transformation.
- To elucidate the signaling pathway through which oncogenic Ras affects Par-4 expression.
- To determine if modulating Par-4 levels can inhibit Ras-induced cancer cell transformation.
Main Methods:
- Utilized the Raf-MEK-ERK signaling pathway analysis.
- Employed the MEK-inhibitor PD98059 to abrogate the pathway.
- Assessed the effects of restoring Par-4 levels on Ras-induced transformation.
- Examined ERK expression and activation.
Main Results:
- Oncogenic Ras was found to down-regulate Par-4 expression through the Raf-MEK-ERK pathway.
- Inhibition of the Raf-MEK-ERK pathway with PD98059 restored Par-4 levels.
- Ectopic expression of Par-4 suppressed ERK activation and oncogenic Ras-induced transformation.
- Restoration of Par-4 was sufficient to inhibit Ras-mediated transformation.
Conclusions:
- Par-4 is identified as a novel target protein that is down-regulated by oncogenic Ras.
- The Raf-MEK-ERK pathway mediates the down-regulation of Par-4 by oncogenic Ras.
- Targeting Par-4 represents a potential therapeutic strategy for cancers driven by oncogenic Ras.